SynthesisOpen heart2026

Cardiovascular disease and amyloidosis in phase III multiple myeloma trials: a systematic review of eligibility, screening and event reporting.

Oliver Henriques Peck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.